An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain

Clinical trial NCT00487435 · COMPLETED

Trial details

NCT number: NCT00487435
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pain Osteoarthritis Low Back Pain

Start date: 2007-06-01
Primary completion: 2009-06-01
Enrollment: 1166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.